C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/755 (2006.01) A61K 38/37 (2006.01) C12N 15/12 (2006.01)
Patent
CA 2678190
The present invention relates to improved variants of the human FVIII having at least one substitution in the A2 and/or C2 domain. The present invention also relates to their use 5 in the treatment of type A hemophilia, particularly in patients with inhibitors.
La présente invention est relative à des variants améliorés du FVIII humain présentant au moins une substitution dans le domaine A2 et/ou C2. La présente invention est également relative à leurs utilisations 5 pour le traitement de l'hémophilie de type A, notamment chez des patients à inhibiteurs.
Blesa Stephane
Delcourt Marc
Marin Sylvie
Menguy Thierry
Negrier Claude
Biomethodes
Fetherstonhaugh & Co.
Hospices Civils de Lyon
LandOfFree
Novel viii factors for the treatment of type a hemophilia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel viii factors for the treatment of type a hemophilia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel viii factors for the treatment of type a hemophilia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1791591